Caj Westlund 2024-08-23 Caj Westlund 2024-08-23 Stockholm3 independently validated at the world-renowned Martini Klinik Läs mer Caj Westlund 2024-07-24 Caj Westlund 2024-07-24 Landmark Stockholm3 multi-ethnical trial published in top-ranked Journal of Clinical Oncology Läs mer Caj Westlund 2024-07-03 Caj Westlund 2024-07-03 Stockholm 3 commercially available in the USA Läs mer Caj Westlund 2024-06-26 Caj Westlund 2024-06-26 Stockholm3 reduces prostate cancer treatment costs and enhances diagnostic precision Läs mer Caj Westlund 2024-05-31 Caj Westlund 2024-05-31 Leadership changes at A3P Biomedical Läs mer Caj Westlund 2024-04-22 Caj Westlund 2024-04-22 Stockholm3 study awarded best abstract in the prostate cancer biopsy indication session at the 2024 European Association of Urology meeting Läs mer Caj Westlund 2024-02-20 Caj Westlund 2024-02-20 Stockholm3 evaluated for Swedish screening program Läs mer Caj Westlund 2024-02-13 Caj Westlund 2024-02-13 Stockholm3 leads to earlier detection of prostate cancer, improved precision, and better health economics Läs mer Caj Westlund 2024-01-29 Caj Westlund 2024-01-29 Landmark Stockholm3 North American clinical trial presented at ASCO-GU Läs mer Caj Westlund 2023-09-13 Caj Westlund 2023-09-13 A3P Biomedical and BioAgilytix enter partnership for Stockholm3 in the USA Läs mer Press contact:Cecilia Edströmcecilia.edstrom@a3p.com+46 72 226 2328
Caj Westlund 2024-08-23 Caj Westlund 2024-08-23 Stockholm3 independently validated at the world-renowned Martini Klinik Läs mer
Caj Westlund 2024-07-24 Caj Westlund 2024-07-24 Landmark Stockholm3 multi-ethnical trial published in top-ranked Journal of Clinical Oncology Läs mer
Caj Westlund 2024-07-03 Caj Westlund 2024-07-03 Stockholm 3 commercially available in the USA Läs mer
Caj Westlund 2024-06-26 Caj Westlund 2024-06-26 Stockholm3 reduces prostate cancer treatment costs and enhances diagnostic precision Läs mer
Caj Westlund 2024-04-22 Caj Westlund 2024-04-22 Stockholm3 study awarded best abstract in the prostate cancer biopsy indication session at the 2024 European Association of Urology meeting Läs mer
Caj Westlund 2024-02-20 Caj Westlund 2024-02-20 Stockholm3 evaluated for Swedish screening program Läs mer
Caj Westlund 2024-02-13 Caj Westlund 2024-02-13 Stockholm3 leads to earlier detection of prostate cancer, improved precision, and better health economics Läs mer
Caj Westlund 2024-01-29 Caj Westlund 2024-01-29 Landmark Stockholm3 North American clinical trial presented at ASCO-GU Läs mer
Caj Westlund 2023-09-13 Caj Westlund 2023-09-13 A3P Biomedical and BioAgilytix enter partnership for Stockholm3 in the USA Läs mer